These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19882093)

  • 21. Chronic Supplementation of Curcumin Enhances the Efficacy of Antidepressants in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
    Yu JJ; Pei LB; Zhang Y; Wen ZY; Yang JL
    J Clin Psychopharmacol; 2015 Aug; 35(4):406-10. PubMed ID: 26066335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study.
    Lopresti AL; Drummond PD
    J Affect Disord; 2017 Jan; 207():188-196. PubMed ID: 27723543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats.
    Li YC; Wang FM; Pan Y; Qiang LQ; Cheng G; Zhang WY; Kong LD
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):435-49. PubMed ID: 19302828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of curcumin on depressive-like behaviors in mice.
    Xu Y; Ku BS; Yao HY; Lin YH; Ma X; Zhang YH; Li XJ
    Eur J Pharmacol; 2005 Jul; 518(1):40-6. PubMed ID: 15987635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond the monoamine hypothesis: mechanisms, molecules and methods.
    Hindmarch I
    Eur Psychiatry; 2002 Jul; 17 Suppl 3():294-9. PubMed ID: 15177084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in antidepressant drugs.
    Priest RG; Baldwin DS; Bullock T; Kibel D; Smeyatsky N; Steinert J
    S Afr Med J; 1992 Jun; Suppl():1-4. PubMed ID: 1609337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacological treatment of depression].
    Castro P; Wilmotte J
    Rev Med Brux; 1994; 15(5):306-10. PubMed ID: 7984847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catecholaminergic strategies for the treatment of major depression.
    Tremblay P; Blier P
    Curr Drug Targets; 2006 Feb; 7(2):149-58. PubMed ID: 16475956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study.
    Bergman J; Miodownik C; Bersudsky Y; Sokolik S; Lerner PP; Kreinin A; Polakiewicz J; Lerner V
    Clin Neuropharmacol; 2013; 36(3):73-7. PubMed ID: 23673908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoamine oxidase inhibitors: a new generation.
    Robinson DS
    Psychopharmacol Bull; 2002; 36(3):124-38. PubMed ID: 12473970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of anti-depressant potential of curcumin against depression induced male albino wistar rats.
    Chang XR; Wang L; Li J; Wu DS
    Brain Res; 2016 Jul; 1642():219-225. PubMed ID: 26972530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental medication treatment approaches for depression.
    Ionescu DF; Papakostas GI
    Transl Psychiatry; 2017 Mar; 7(3):e1068. PubMed ID: 28323287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Major depression: emerging therapeutics.
    Sen S; Sanacora G
    Mt Sinai J Med; 2008; 75(3):204-25. PubMed ID: 18704976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination antidepressants are not yet proven therapy in the treatment of depression.
    Olver J; Ellen S; Norman T
    Australas Psychiatry; 2007 Jun; 15(3):248-9. PubMed ID: 17516193
    [No Abstract]   [Full Text] [Related]  

  • 35. Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study.
    Lopresti AL; Maes M; Maker GL; Hood SD; Drummond PD
    J Affect Disord; 2014; 167():368-75. PubMed ID: 25046624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressant-like effects of curcumin in chronic mild stress of rats: involvement of its anti-inflammatory action.
    Jiang H; Wang Z; Wang Y; Xie K; Zhang Q; Luan Q; Chen W; Liu D
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():33-9. PubMed ID: 23876788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The olfactory bulbectomized rat as a model of depression: The hippocampal pathway.
    Morales-Medina JC; Iannitti T; Freeman A; Caldwell HK
    Behav Brain Res; 2017 Jan; 317():562-575. PubMed ID: 27633561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current antidepressant drugs: their clinical use.
    Hollister LE
    Drugs; 1981 Aug; 22(2):129-52. PubMed ID: 6114851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NMDA GluN2B receptors involved in the antidepressant effects of curcumin in the forced swim test.
    Zhang L; Xu T; Wang S; Yu L; Liu D; Zhan R; Yu SY
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():12-7. PubMed ID: 22960607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs.
    Goodman WK; Charney DS
    J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):6-24. PubMed ID: 3900056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.